External Affairs Minister Dr S. Jaishankar on Thursday spoke to his Gambian counterpart Dr. Mamadou Tangara and conveyed condolences on the deaths of young children allegedly linked to the contaminated cough syrups produced in India.
He assured Tangara that serious investigation is being undertaken by appropriate authorities in India to ascertain the facts over World Health Organisation alerts of India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 children's death".
"In a telecon with Gambian FM Dr. Mamadou Tangara, conveyed our deepest condolences on the deaths of young children recently. Underlined that matter is being seriously investigated by appropriate authorities. We agreed to remain in touch," the Minister said in a tweet.
The World Health Organisation had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".
Meanwhile, the centre has formed a four-member panel to analysis and examine the detailed report shared by the World Health Organisation on the issue.
The committee will examining and analysing adverse event reports, causal relationship and all related details shared by WHO, and will suitably advise and recommend to the DCGI about further course of action. The committee will be chaired by Dr Y.K Gupta, Vice Chairperson, Standing National Committee on Medicines.
--IANS
avr/vd
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)